Literature DB >> 500771

Rubella virus antigen in lymphocytes of patients with angioimmunoblastic lymphadenopathy (AIL).

G R Krueger, M Bergholz, H H Bartsch, R Fischer, A Schauer.   

Abstract

Lymph node sections from 14 patients with angioimmunoblastic lymphadenopathy (AIL) were incubated with fluorescein-labeled specific antiserum against rubella virus antigen. In lymphoid cells from 11 patients intracytoplasmic rubella antigen was demonstrated. The results support the idea of a persistent virus infection in AIL.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 500771     DOI： 10.1007/bf00411114

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


  12 in total

1.  Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease.

Authors:  R J Lukes; B H Tindle
Journal:  N Engl J Med       Date:  1975-01-02       Impact factor: 91.245

2.  Immunomorphologic methods in routine pathology. Application of immunofluorescence and the unlabeled antibody-enzyme (peroxidase-antiperoxidase) technique to formalin fixed paraffin embedded kidney biopsies.

Authors:  H Denk; G Syré; E Weirich
Journal:  Beitr Pathol       Date:  1977-05

3.  Optimal labeling of antibody with fluorescein isothiocyanate.

Authors:  R S Spendlove
Journal:  Proc Soc Exp Biol Med       Date:  1966-06

4.  Malignant lymphomas and plasmacytosis in mice under prolonged immunosuppression and persistent antigenic stimulation.

Authors:  G R Krueger; R A Malmgren; C W Berard
Journal:  Transplantation       Date:  1971-02       Impact factor: 4.939

5.  Angioimmunoblastic lymphadenopathy in persistent virus infection?

Authors:  G R Krueger; G Konorza
Journal:  Lancet       Date:  1977-11-26       Impact factor: 79.321

6.  Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course.

Authors:  G Frizzera; E M Moran; H Rappaport
Journal:  Am J Med       Date:  1975-12       Impact factor: 4.965

7.  Immunoblastic lymphadenopathy. Evolution into a malignant lymphoma with plasmacytoid features.

Authors:  R I Fisher; E S Jaffe; R C Braylan; J C Andersen; H K Tan
Journal:  Am J Med       Date:  1976-10       Impact factor: 4.965

8.  Immunoblastic lymphadenopathy with pulmonary infiltrates, hypocomplementemia and vasculitis. A hyperimmune syndrome.

Authors:  D Weisenburger; J Armitage; F Dick
Journal:  Am J Med       Date:  1977-12       Impact factor: 4.965

9.  [Immunoblastic lymphadenopathy--malignant neoplasia or hyperimmune reaction? (author's transl)].

Authors:  A Schoengen; H Feyen; O Haferkamp; H Heimpel; B Kubanek
Journal:  Klin Wochenschr       Date:  1977-03-15

10.  THE PRECIPITIN REACTION BETWEEN TYPE III PNEUMOCOCCUS POLYSACCHARIDE AND HOMOLOGOUS ANTIBODY : II. CONDITIONS FOR QUANTITATIVE PRECIPITATION OF ANTIBODY IN HORSE SERA.

Authors:  M Heidelberger; F E Kendall
Journal:  J Exp Med       Date:  1935-03-31       Impact factor: 14.307
View more
  2 in total

1.  Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma.

Authors:  L M Weiss; J G Strickler; R F Dorfman; S J Horning; R A Warnke; J Sklar
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

2.  Rapidly fatal respiratory failure and angioimmunoblastic lymphadenopathy: possible contributions of immunoblastic leukaemia, chemotherapy, and multiple antibodies directed against mature blood cells.

Authors:  P M Trenchard; J A Whittaker; J Gough; H Parry
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.